Introduction Extracellular vesicles (EVs) and particles (EPs) represent reliable biomarkers
for disease detection. Their role in the inflammatory microenvironment of severe COVID-19 …

COVID‐19 is characterized by a wide spectrum of disease severity, whose indicators and
underlying mechanisms need to be identified. The role of extracellular vesicles (EVs) in …

Sars-Cov-2 infection causes fever and cough that may rapidly lead to acute respiratory
distress syndrome (ARDS). Few biomarkers have been identified but, unfortunately, these …

Abstract Coronavirus disease 2019 (COVID‐19) has been a major public health burden. We
hypothesised that circulating extracellular vesicles (cEVs), key players in health and …

Background aims Coronavirus disease 2019 (COVID-19) is characterized by a broad
spectrum of clinical manifestations with the potential to progress to multiple organ …

Background Extracellular vesicles (EVs) are a valuable source of biomarkers and display
the pathophysiological status of various diseases. In COVID-19, EVs have been explored in …

Plasma concentrations of extracellular vesicles (EVs) originating from cells involved in
COVID-19-associated coagulopathy (CAC), their longitudinal trend and association with …

COVID-19 infection caused by the novel severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) has resulted in a global pandemic with the number of deaths growing …

Severe COVID-19 infections present with cytokine storms, hypercoagulation, and acute
respiratory distress syndrome, with extracellular vesicles (EVs) being involved in …

Infection with SARS‐CoV‐2 is associated with thromboinflammation, involving thrombotic
and inflammatory responses, in many COVID‐19 patients. In addition, immune dysfunction …